1083 related articles for article (PubMed ID: 26416678)
1. Present and future challenges of induced pluripotent stem cells.
Ohnuki M; Takahashi K
Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140367. PubMed ID: 26416678
[TBL] [Abstract][Full Text] [Related]
2. Induced pluripotent stem cells: progress and future perspectives in the stem cell world.
Rezanejad H; Matin MM
Cell Reprogram; 2012 Dec; 14(6):459-70. PubMed ID: 23035654
[TBL] [Abstract][Full Text] [Related]
3. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
[TBL] [Abstract][Full Text] [Related]
4. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
[TBL] [Abstract][Full Text] [Related]
5. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
Menon S; Shailendra S; Renda A; Longaker M; Quarto N
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822
[TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cells in medicine and biology.
Takahashi K; Yamanaka S
Development; 2013 Jun; 140(12):2457-61. PubMed ID: 23715538
[TBL] [Abstract][Full Text] [Related]
7. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
[TBL] [Abstract][Full Text] [Related]
8. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine.
Gomes KM; Costa IC; Santos JF; Dourado PM; Forni MF; Ferreira JC
Rev Assoc Med Bras (1992); 2017 Feb; 63(2):180-189. PubMed ID: 28355380
[TBL] [Abstract][Full Text] [Related]
10. Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine.
Parrotta EI; Scalise S; Scaramuzzino L; Cuda G
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744081
[TBL] [Abstract][Full Text] [Related]
11. Turning straw into gold: directing cell fate for regenerative medicine.
Cohen DE; Melton D
Nat Rev Genet; 2011 Apr; 12(4):243-52. PubMed ID: 21386864
[TBL] [Abstract][Full Text] [Related]
12. microRNAs: important regulators of stem cells.
Li N; Long B; Han W; Yuan S; Wang K
Stem Cell Res Ther; 2017 May; 8(1):110. PubMed ID: 28494789
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis in Porcine Pluripotent Cells: From ICM to iPSCs.
Kim E; Hyun SH
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27626414
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
15. Biomaterial aided differentiation and maturation of induced pluripotent stem cells.
Velmurugan BK; Bharathi Priya L; Poornima P; Lee LJ; Baskaran R
J Cell Physiol; 2019 Jun; 234(6):8443-8454. PubMed ID: 30565686
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
de Lázaro I; Yilmazer A; Kostarelos K
J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
[TBL] [Abstract][Full Text] [Related]
17. High throughput sequencing identifies an imprinted gene, Grb10, associated with the pluripotency state in nuclear transfer embryonic stem cells.
Li H; Gao S; Huang H; Liu W; Huang H; Liu X; Gao Y; Le R; Kou X; Zhao Y; Kou Z; Li J; Wang H; Zhang Y; Wang H; Cai T; Sun Q; Gao S; Han Z
Oncotarget; 2017 Jul; 8(29):47344-47355. PubMed ID: 28476045
[TBL] [Abstract][Full Text] [Related]
18. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
19. Recent technological updates and clinical applications of induced pluripotent stem cells.
Diecke S; Jung SM; Lee J; Ju JH
Korean J Intern Med; 2014 Sep; 29(5):547-57. PubMed ID: 25228828
[TBL] [Abstract][Full Text] [Related]
20. Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases.
Li R; Bai Y; Liu T; Wang X; Wu Q
Protein Cell; 2013 Jun; 4(6):415-24. PubMed ID: 23686735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
